Cancer and systemic inflammation: treat the tumour and treat the host
Top Cited Papers
Open Access
- 18 February 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 110 (6), 1409-1412
- https://doi.org/10.1038/bjc.2014.90
Abstract
Determinants of cancer progression and survival are multifactorial and host responses are increasingly appreciated to have a major role. Indeed, the development and maintenance of a systemic inflammatory response has been consistently observed to confer poorer outcome, in both early and advanced stage disease. For patients, cancer-associated symptoms are of particular importance resulting in a marked impact on day-to-day quality of life and are also associated with poorer outcome. These symptoms are now recognised to cluster with one another with anorexia, weight loss and physical function forming a recognised cluster whereas fatigue, pain and depression forming another. Importantly, it has become apparent that these symptom clusters are associated with presence of a systemic inflammatory response in the patient with cancer. Given the understanding of the above, there is now a need to intervene to moderate systemic inflammatory responses, where present. In this context the rationale for therapeutic intervention using nonselective anti-inflammatory agents is clear and compelling and likely to become a part of routine clinical practice in the near future. The published literature on therapeutic intervention using anti-inflammatory agents for cancer-associated symptoms was reviewed. There are important parallels with the development of useful treatments for the systemic inflammatory response in patients with rheumatological disease and cardiovascular disease.Keywords
This publication has 31 references indexed in Scilit:
- Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic SystemClinical Cancer Research, 2013
- Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: Three peas in a pod? – analysis from a multicenter cross sectional studyActa Oncologica, 2013
- Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced CancerJournal of Clinical Oncology, 2013
- The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced CancerThe Oncologist, 2013
- Cancer and systemic inflammation: stage the tumour and stage the hostBritish Journal of Cancer, 2013
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancerCancer Treatment Reviews, 2013
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- Cancer, cachexia, prostanoids, and NSAIDsActa Oncologica, 2012
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer SurvivalNew England Journal of Medicine, 2012
- Symptoms tell it all: A systematic review of the value of symptom assessment to predict survival in advanced cancer patientsCritical Reviews in Oncology/Hematology, 2012